Perspective Therapeutics, Inc. · AMEX:CATX
Morgan Stanley reported a 6.00% stake in Perspective Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 12, 2026
Morgan Stanley reported a 6.00% stake in Perspective Therapeutics, Inc., 4,461,893 shares, as a passive investor on Dec 31, 2025. Filed Feb 12, 2026 (Schedule 13G).
- Stake
- 6.00%
- Shares
- 4,461,893
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 6.00% | 4,461,893 |
Source
Related
- Perspective Therapeutics, Inc.
- Morgan Stanley
- Perspective Therapeutics, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13D/A · Lantheus Holdings, Inc. · Sep 23, 2026
- Form 4 · Lantheus Alpha Therapy, LLC · Sep 8, 2026
- Form 4 · Lantheus Holdings, Inc. · Sep 4, 2026
- Form 4 · Lantheus Alpha Therapy, LLC · Sep 4, 2026
- Schedule 13D/A · Lantheus Holdings, Inc. · Sep 4, 2026